EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on the NexACT® drug delivery technology, today announced that it will present at the 15th Annual BioPartnering Europe Conference in London, October 7-9, 2007. The Company will provide an update on its topical treatments under development including erectile dysfunction, female sexual arousal disorder and onychomycosis (nail fungus). Since 1992, BioPartnering Europe has been a leading meeting forum for American and European biotechnology and pharmaceutical companies.
